Cell & Gene Therapies

© GettyImages/metamorworks

Gamma Biosiences takes majority stake in Mirus Bio

By Jane Byrne

Gamma Biosciences has taken a controlling investment in Mirus Bio, an innovator and developer of biomimetic, cell-adaptive lipid-polymer nanocomplexes (LPNCs) for nucleic acid delivery based in Wisconsin in the US.

Chicago emerging as life science and biopharma hub

Chicago emerging as a life science and biopharma hub

By Jane Byrne

Many turn to Boston and North Carolina’s Research Triangle to set up life science companies, but Chicago is now also fast becoming a draw in this respect. The city is emerging as a life science and biopharma hub and seems poised for even further growth,...

© GettyImages/Dilok Klaisataporn

PPD adds cell and gene therapy testing capabilities to Irish site

By Jane Byrne

US contract research organization, PPD Inc, is expanding its Athlone, Ireland, GMP laboratory, significantly increasing the size of its current facility and adding cell and gene therapy (CGT) testing to the operation’s portfolio of services.

Follow us

Products

View more

Webinars